Funding for this research was provided by:
American Cancer Society (RSGI-15-151-01)
Received: 19 June 2019
Revised: 26 September 2019
Accepted: 27 November 2019
First Online: 8 January 2020
Compliance with Ethical Standards
: The Yale University Institutional Review Board approved this study.
: Dr. Gross has received research funding through Yale from Johnson & Johnson and Pfizer. In addition, Dr. Gross has received compensation from Flatiron Health for travel and speaking. Dr. Richman has received research funding through NCATS (KL2 TR001862). No other disclosures are reported.
Free to read: This content has been made available to all.